STOCK TITAN

LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

LENSAR, Inc. (NASDAQ: LNSR) will release its third quarter 2021 financial results on November 8, 2021, before market open. A conference call and webcast will follow at 8:30am ET on the same day to discuss these results and corporate highlights. LENSAR specializes in advanced femtosecond laser technologies for cataract treatment, aiming to improve visual outcomes for patients through its proprietary laser system.

Positive
  • LENSAR is focused on advanced femtosecond laser technology for cataract treatment.
  • The upcoming Q3 2021 earnings release indicates active corporate engagement with stakeholders.
Negative
  • None.

ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s third quarter 2021 financial results will be released before market open on Monday, November 8, 2021. LENSAR’s management will host a conference call and webcast at 8:30am ET on Monday, November 8, 2021 to discuss the financial results and recent corporate highlights.

To participate by telephone, please dial (833) 312-1363 (Domestic) or (236) 712-2498 (International). The conference ID number is 5587659. To access the live webcast, please go to the Investor Relations section of LENSAR’s website at www.lensar.com. Following the live webcast, an archived version of the call will be available on the website.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

Thomas R. Staab, II, CFO

ir.contact@lensar.com

Lee Roth / Cameron Radinovic

Burns McClellan for LENSAR

lroth@burnsmc.com / cradinovic@burnsmc.com

Source: LENSAR, Inc.

FAQ

When will LENSAR release its Q3 2021 financial results?

LENSAR will release its Q3 2021 financial results on November 8, 2021.

What time is the LENSAR conference call for financial results?

The conference call will be held at 8:30am ET on November 8, 2021.

How can I access LENSAR's Q3 2021 earnings call?

You can access LENSAR's Q3 2021 earnings call via telephone or the live webcast on their website.

What is the focus of LENSAR's technology?

LENSAR focuses on advanced femtosecond laser surgical solutions for cataract treatment.

LENSAR, Inc.

NASDAQ:LNSR

LNSR Rankings

LNSR Latest News

LNSR Stock Data

51.06M
11.61M
19.56%
41.8%
0.63%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ORLANDO